Walleye Trading’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Walleye Trading’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,169	Closed	-$583K	–	5367
2023 Q1	$583K	Buy	+25,169	New	+$600K	﹤0.01%	2661
2022 Q4	–	Sell	-27,998	Closed	-$550K	–	5573
2022 Q3	$550K	Buy	+27,998	New	+$562K	﹤0.01%	2814
2020 Q3	–	Sell	-5,963	Closed	-$69K	–	4766
2020 Q2	$69K	Buy	+5,963	New	+$82.2K	﹤0.01%	3689
2017 Q1	–	Sell	-7,440	Closed	-$424K	–	5279
2016 Q4	$424K	Buy	+7,440	New	+$450K	﹤0.01%	2216

Other funds holding KDNY

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Walleye Trading's KDNY Position: Q2 2023 in Review

Walleye Trading sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2023, closing a stake of 25,169 shares — an estimated $583K sold.

Walleye Trading first reported a position in KDNY in Q4 2016 and held it in 4 quarters. The position peaked at $583K in Q1 2023. 185 funds tracked by Wall St. Rank hold KDNY as of Q2 2023.

Walleye Trading reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Walleye Trading sold 25,169 Chinook Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $583K.
Walleye Trading first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2016 and held it in 4 quarters.
Walleye Trading's Chinook Therapeutics, Inc. Common Stock position peaked at $583K in Q1 2023.
185 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.